We also found that CLK2 is amplified and overexpressed in human glioblastomas and that its downregulation inhibits glioblastoma cell growth in cell culture models and glioblastoma tumorigenesis in a xenograft assay. This evidence concerns the gene CLK2 and glioblastoma.